SEC 13F Intelligence

Viking Global Investors LP / BSX

Viking Global Investors LP’s Boston Scientific Corp Position

Does Viking Global Investors LP own Boston Scientific Corp (BSX)? Not currently — the last reported position was 2.51M shares worth $239M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$239M
Q4 2025
Shares
2.51M
% of Portfolio
+0.64%
Quarters Held
27
position exited

Position History BSX

Reported value by quarter
Q4 ’18: $184MQ4 ’18Q1 ’19: $124MQ2 ’19: $395MQ3 ’19: $424MQ4 ’19: $836MQ4 ’19Q1 ’20: $1.0BQ2 ’20: $648MQ3 ’20: $719MQ4 ’20: $1.1BQ4 ’20Q1 ’21: $692MQ2 ’21: $569MQ3 ’21: $298MQ4 ’21: $805MQ4 ’21Q1 ’22: $805MQ2 ’22: $546MQ3 ’22: $626MQ4 ’22: $441MQ4 ’22Q1 ’23: $57MQ3 ’23: $59MQ4 ’23: $131MQ1 ’24: $118MQ1 ’24Q3 ’24: $81MQ4 ’24: $194MQ1 ’25: $240MQ2 ’25: $327MQ2 ’25Q3 ’25: $258MQ4 ’25: $239Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20252.51M$239M+0.64%
Q3 20252.64M$258M+0.67%
Q2 20253.05M$327M+0.95%
Q1 20252.38M$240M+0.76%
Q4 20242.17M$194M+0.63%
Q3 2024967.2K$81M+0.30%
Q1 20241.72M$118M+0.44%
Q4 20232.27M$131M+0.48%
Q3 20231.11M$59M+0.24%
Q1 20231.14M$57M+0.27%
Q4 20229.53M$441M+2.21%
Q3 202216.16M$626M+2.89%
Q2 202214.65M$546M+2.50%
Q1 202218.96M$805M+2.32%
Q4 202118.96M$805M+2.34%
Q3 20216.87M$298M+0.83%
Q2 202113.32M$569M+1.73%
Q1 202117.90M$692M+2.06%
Q4 202029.99M$1.1B+2.96%
Q3 202018.83M$719M+2.60%
Q2 202018.46M$648M+2.80%
Q1 202031.82M$1.0B+5.40%
Q4 201918.49M$836M+3.92%
Q3 201910.42M$424M+2.21%
Q2 20199.20M$395M+1.77%
Q1 20193.22M$124M+0.71%
Q4 20185.20M$184M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Viking Global Investors LP’s full portfolio or all institutional holders of BSX.